Loading...
Loading...
In a report published Monday, Morgan Stanley analyst Steve Beuchaw reiterated an Underweight rating on
Varian Medical SystemsVAR, but removed the $76.00 price target.
In the report, Morgan Stanley noted, “ASTRO's reimbursement update confirmed that a new radiation oncology rate structure will bundle codes and stratify rates by case complexity. We continue to see downside to payment levels and pressure ahead for the US market.”
Varian Medical Systems closed on Friday at $85.33.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in